SOLANA CO
HSDTNASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- $1.19 β $4.36
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 58.4M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $6M
- Last Q Revenue
- $3M
- P/E Ratio
- 0.4
- P/S Ratio
- 5.9x
- EPS (TTM)
- $3.54
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +713.6%
SOLANA CO
HSDTAbout SOLANA CO
Solana Co. is a medical device firm specializing in neurotechnology, dedicated to improving neurological wellness. The company's strategy involves developing, licensing, and acquiring innovative, non-invasive platform technologies. These technologies are designed to enhance the brain's intrinsic capacity for self-healing and mitigate the effects of neurological diseases or trauma. A prime example of their work is the development of an investigational portable neuromodulation stimulator. This device uniquely delivers neurostimulation through the tongue. Clinical studies have indicated that this approach significantly enhances the efficacy of physical exercises for individuals experiencing neurological symptoms stemming from conditions like disease or trauma, including mild-to-moderate traumatic brain injury. Established on March 13, 2014, Solana Co. maintains its headquarters in Newtown, Pennsylvania.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.